[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370298-105":59,"doc-detail-370298-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cancer-stem-cells-and-niches-challenges-in-immunotherapy-resistance","Cancer stem cells and niches: challenges in immunotherapy resistance","","Cancer stem cells (CSCs) are key drivers of tumor progression, metastasis, immune evasion, and therapeutic resistance. With strong self-renewal and adaptability, CSCs undergo “CSC plasticity,” transitioning between stem-like and differentiated states under external stimuli. Their resilience extends beyond intrinsic traits through the CSC niche, a specialized microenvironment that provides immune-privileged protection, maintains stemness, and promotes immune suppression. This review synthesizes how CSC–niche mechanisms fuel immunotherapy resistance and outlines the need for integrated strategies to overcome these barriers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-stem-cells-and-niches-challenges-in-immunotherapy-resistance/370298/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-stem-cells-and-niches-challenges-in-immunotherapy-resistance/370298.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are cancer stem cells (CSCs) and why are they important in cancer progression?","Question",{"text":112,"@type":113},"CSCs are central to tumor progression and metastasis and also contribute to immune evasion and therapeutic resistance. They sustain malignant growth through self-renewal capabilities.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is “CSC plasticity” and what triggers these state changes?",{"text":117,"@type":113},"“CSC plasticity” refers to dynamic transitions between stem-like and differentiated states in response to external stimuli. Therapeutic interventions, hypoxia, and metabolic stress are highlighted as examples.",{"name":119,"@type":110,"acceptedAnswer":120},"How do CSC niches contribute to immunotherapy resistance?",{"text":121,"@type":113},"CSCs reside in specialized niches that provide immune-privileged protection, sustain stemness, and foster immune suppression. This niche-mediated support helps drive resistance to immunotherapies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370298,1790219395,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Pan etal. Molecular Cancer (2025) 24:52 [https://doi.org/10.1186/s12943-025-02265-2](https://doi.org/10.1186/s12943-025-02265-2)  \nMolecular Cancer  \nREVIEW Open Access  \nCancer stem cells and niches: challenges in immunotherapy resistance  \nYonglong Pan 1,2,3†, Chaoyi Yuan 1,2†, Chenglong Zeng 1,2†, Chaoyang Sun4, Limin Xia2,5, Guihua Wang2,6, Xiaoping Chen 1,2,7, Bixiang Zhang 1,2*, Jianfeng Liu3* and Ze-yang Ding 1,2*  \nAbstract  \nCancer stem cells (CSCs) are central to tumor progression, metastasis, immune evasion, and therapeutic resistance. Characterized by remarkable self-renewal and adaptability, CSCs can transition dynamically between stem-like and differentiated states in response to external stimuli, a process termed “CSC plasticity.” This adaptability underpins their resilience to therapies, including immune checkpoint inhibitors and adoptive cell therapies (ACT) . Beyond intrinsic properties, CSCs reside in a specialized microenvironment—the CSC niche—which provides immuneprivileged protection, sustains their stemness, and fosters immune suppression. This review highlights the critical role of CSCs and their niche in driving immunotherapy resistance, emphasizing the need for integrative approaches to overcome these challenges.  \nIntroduction  \nFor decades, Cancer stem cells (CSCs) have been central to the understanding of tumor biology, playing critical roles in tumor initiation, metastasis, immune evasion, and therapeutic resistance. The concept of CSCs has evolved significantly since their initial identification in 1994 through studies on acute myeloid leukemia (AML), which revealed a CD34+/CD38 − cell subpopulation with  \n†Yonglong Pan, Chaoyi Yuan and Chenglong Zeng contributed equally to this work.  \n*Correspondence:  \nBixiang Zhang [bixiangzhang@hust.edu.cn](bixiangzhang@hust.edu.cn)[ ](bixiangzhang@hust.edu.cn)Jianfeng Liu [jfliu@hust.edu.cn](jfliu@hust.edu.cn)  \nZe-yang Ding [zyding@tjh.tjmu.edu.cn](zyding@tjh.tjmu.edu.cn)  \n1Hepatic Surgery Center, Clinical Medical Research Center of Hepatic Surgery at Hubei Province, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 2Hubei Key Laboratory of Hepato-Pancreatic-Biliary Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China  \nstem cell-like renewal capabilities and high tumor-initiating potential [1]. Unlike their differentiated progeny, CSCs possess a unique ability to sustain the growth of malignant cell populations indefinitely. This property not only drives tumor progression but also endows CSCs with resilience against conventional therapies that target rapidly dividing cells, as CSCs often exist in a quiescent or slow-cycling state, allowing them to evade therapeutic  \n3Cellular Signaling laboratory, Key laboratory of Molecular Biophysics of MOE, International Research Center for Sensory Biology and Technology of MOST, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China  \n4National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center, Key Laboratory of the MOE, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China  \n5Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 6Tongji Hospital, GI Cancer Research Institute, Huazhong University of Science and Technology, Wuhan 430030, China  \n7Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Ministry of Education, National Health Commission, Chinese Academy of Medical Sciences, Wuhan 430030, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, d","cbCaiodhWRaupjkb","https://ap.wps.com/l/cbCaiodhWRaupjkb","pdf",2510541,22,"English","# Introduction\n## Cancer stem cells, therapeutic resistance, and immune evasion\n## CSC plasticity and dynamic state transitions\n## CSC niches as immune-privileged microenvironments","[{\"question\":\"What are cancer stem cells (CSCs) and why are they important in cancer progression?\",\"answer\":\"CSCs are central to tumor progression and metastasis and also contribute to immune evasion and therapeutic resistance. They sustain malignant growth through self-renewal capabilities.\"},{\"question\":\"What is “CSC plasticity” and what triggers these state changes?\",\"answer\":\"“CSC plasticity” refers to dynamic transitions between stem-like and differentiated states in response to external stimuli. Therapeutic interventions, hypoxia, and metabolic stress are highlighted as examples.\"},{\"question\":\"How do CSC niches contribute to immunotherapy resistance?\",\"answer\":\"CSCs reside in specialized niches that provide immune-privileged protection, sustain stemness, and foster immune suppression. This niche-mediated support helps drive resistance to immunotherapies.\"}]","Cancer stem cells and niches: challenges in immunotherapy resistance | PDF",1790187844,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1ce37a61211690eb55ca40c6cd3a3ef.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e8bf6a08819aaec528be6bd02e939be.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19475fe99153bd8a5f917bda3d19aae2.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa47696dd6191ff7a0284c6c1f6f1ec8.webp",980,1306]